The microcirculation of choroidal and ciliary body melanomas

Eye

Volumn 11, Issue 2, 1997, Pages 227-238

  Folberg, Robert ^a,d   Mehaffey, Mary ^a   Gardner, Lynn M ^a   Meyer, Margaret ^a   Rummelt, Volker ^b   Pe'er, Jacob ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Angiogenesis; Extracellular matrix; Indocyanine green angiography; Melanoma; Metastasis; Prognosis; Type VI collagen; Ultrasound

Indexed keywords

ANGIOGENESIS; ARCHITECTURE; CANCER GRADING; CELL TYPE; CHOROID MELANOMA; CILIARY BODY TUMOR; CONFERENCE PAPER; CYTOLOGY; DIAGNOSTIC IMAGING; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; MICROCIRCULATION; PHENOTYPE; PROGNOSIS; TUMOR BIOPSY; TUMOR CELL;

EID: 0030979545     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1997.57     Document Type: Conference Paper

References (112)

1. Callender GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931;36:131-42.
2. Wilder HC, Callender GR. Malignant melanoma of the choroid: further studies on prognosis by histologic type and fiber content. Am J Ophthalmol 1939; 22:851-5.
3. Callender GR, Wilder HC, Ash JE. Five hundred malignant melanomas of the choroid and ciliary body followed five years or longer. Trans Am Acad Ophthalmol Otolaryngol 1942;46:223-30.
4. Paul EV, Parnell, BL, Fraker M. Prognosis of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin 1962;2:387-402.
5. Jensen OA. Malignant melanomas of the uvea in Denmark, 1943-1952: a clinical, histopathological, and prognostic study. Acta Ophthalmol (Suppl) 1963;75:141-89.
6. McLean IW, Foster WD, Zimmerman LE. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977;95:48-58.
7. Raivio I. Uveal melanomas in Finland: an epidemiological, clinical, histological, and prognostic study. Acta Ophthalmol (Suppl) 1977;133:5-64.
8. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63-9.
9. McLean IW, Foster WD, Zimmerman LE. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 1982;13:123-32.
10. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-9.
11. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 1992;33:1919-22.
12. Gamel JW, McLean IW, Foster WD, Zimmerman LE. Uveal melanomas: correlation of cytologic features with prognosis. Cancer 1978;41:1897-901.
13. Gamel JW, McLean IW, Greenberg RA, Zimmerman LE, Lichtenstein SJ. Computerized histologic assessment of malignant potential: a method for determining the prognosis of uveal melanomas. Hum Pathol 1982;13:893-7.
14. McCurdy J, Gamel J, McLean I. A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from H&E slides. Pathol Res Pract 1991;187:1025-7.
15. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? Theor Biol 1982;99:31-68.
16. Madri JA, Basson MD. Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function. Lab Invest 1992; 66:519-21.
17. Iozzo RV. Tumor stroma as a regulator of neoplastic behavior: agonostic and antagonistic elements embedded in the same connective tissue. Lab Invest 1995;73:157-60.
18. Vernon RB, Sage EH. Between molecules and morphology: extracellular matrix and creation of vascular form. Am J Pathol 1995;147:873-83.
19. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
20. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
21. Weidner N, Sample JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
22. Srivastava A, Laidler P, Hughes LE, Woodcock JP, Shedden EJ. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Clin Oncol 1986;22:1205-9.
23. Fallowfield ME, Cook MG. Lymphatics in primary cutaneous melanoma. Am J Surg Pathol 1990;14: 370-4.
24. Carnochan P, Briggs JC, Westbury G, Davies AJS. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. Br J Cancer 1991;64:102-7.
25. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
26. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992;168:257-62.
27. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma. Cancer 1993;73:678-87.
28. Lipponen PK. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer. J Cancer Res Clin Oncol 1993;119:295-300.
29. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GNA, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinoma. Br J Urol 1994;74:762-6.
30. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995;87:1603-12.
31. Roychowdhury DF, Tseng A, Fu KK, Windberg V, Weidner N. New prognostic factors in nasopharyngeal carcinoma: tumor angiogenesis and C-erbB2 expression. Cancer 1996;77:1419-26.
32. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-72.
33. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
34. Lindmark G, Gerdin B, Sundberg C. Pahlman L, Bergstrom R, Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996;14:461-6.
35. Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995;147:1049-56.
36. Page DL, Jensen RA. Angiogenesis in human breast carcinoma: what is the question? Hum Pathol 1995;26:1173-4.
37. Costello P, McCann A, Carney DN, Dervan PA. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 1995;26:1181-4.
38. Goulding H, Rashid NFAR, Robertson JF, Bell JA, Elston CW, Blarney RW, Ellis IO. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 1995;26:1196-200.
39. Ettinger L, Doljanski F. On the generation of form by the continuous interactions between cells and their extracellular matrix. Biol Rev Camb Philos Soc 1992;67:459-89.
40. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992; 23:1298-305.
41. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100: 1389-98.
42. Sakamoto T, Sakamoto H, Murphy TL, Spec C, Soriano D, Ishibashi T, et al. Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells. Arch Ophthalmol 1995;113:512-20.
43. Elder DE, Murphy GF. Melanocytic tumors of the skin. Washington, DC: Armed Forces Institute of Pathology, 1991.
44. Gass JDM. Problems in the differential diagnosis of choroidal nevi and malignant melanomas: the XXXIII Edward Jackson Memorial Lecture. Am J Ophthalmol 1977;83:299-323.
45. Folberg R. Tumor progression in ocular melanomas. J Invest Dermatol 1993;100:326-31S.
46. Naumann G, Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol 1996;76:784-96.
47. Naumann G. Pigmentierte Naevi der Aderhaut und des Ciliarkörpers. Adv Ophthalmol 1970;23:187-272.
48. Rummelt V, Folberg R, Rummelt C, Gruman LM, Hwang T, Woolson RF, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid: a comparative histopathologic and ultrastructural study. Ophthalmology 1994;101:718-27.
49. Rubin P, Casarett G. Microcirculation of tumors. I. Anatomy, function, and necrosis. Clin Radiol 1966; 17:220-9.
50. Eddy HA, Casarett GW. Development of the vascular system in the hamster malignant neurilemmoma. Microvasc Res 1973;6:63-82.
51. Less JR, Skalak TC, Sevick EM, Jain RK, Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991;51:265-73.
52. Gaehtgens P. Why networks? Int J Microcirc Clin Exp 1992;11:123-32.
53. Gaudin PB, Rosai J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms: a diagnostic clue and potential pitfall. Am J Surg Pathol 1995;19:642-52.
54. Groom AC, Ellis CG, Wrigley SJ, Potter RF. Capillary network morphology and capillary flow. Int J Microcirc Clin Exp 1995;15:223-30.
55. Skinner SA, Frydman GM, O'Brien PE. Microvascular structure of benign and malignant tumors of the colon in humans. Dig Dis Sci 1995;40:373-84.
56. Wilkins BS, Jones DB. Vascular networks within the stroma of human long-term bone marrow cultures. J Pathol 1995;177:295-301.
57. Brooks JJ, Disorders of soft tissue. In: Sternberg SS, editor. Diagnostic surgical pathology. 2nd ed. New York: Raven Press, 1996:147-229.
58. Rummelt V, Gardner LM, Folberg R, Beck S, Knosp B, Moninger TO, Moore KC. Three-dimensional relationships between tumor cells and microcirculation using double cyanine-immunolabeling, laser scanning confocal microscopy and computer-assisted reconstruction: an alternative to cast corrosion preparations. J Histochem Cytochem 1994;42:681-6.
59. Gragoudas ES, Goitein M, Verhey L, Muzenreider J, Suit HD, Koehler A. A Proton beam irradiation: an alternative to enucleation for intraocular melanomas. Ophthalmology 1980;87:571-81.
60. Zinn KM, Stein/Pokorny K, Jakobiec FA, Friedman AH, Gragoudas ES, Ritch R. Proton-beam irradiated epithelial cell melanoma of the ciliary body. Ophthalmology 1981;88:1315-21.
61. Seddon JM, Gragoudas ES, Albert DM. Ciliary body and choroidal melanomas treated by proton beam irradiation: histopathologic study of eyes. Arch Ophthalmol 1983;101:1402-8.
62. Messmer E, Bornfeld N, Foerster M, Schilling H, Wessing A. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 1992;230:391-6.
63. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol 1992;110:1112-8.
64. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
65. Sallet G, Amoaku WMK, Lafaut BA, Brabant P, Delaey JJ. Indocyanine green angiography of choroidal tumors. Graefes Arch Clin Exp Ophthalmol 1995;233:677-89.
66. Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 1989;81:570-6.
67. Foss AJE, Alexander RA, Jeffries LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res 1996;56:2900-3.
68. Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of sinusoids in hepatocellular carcinoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch Pathol Lab Med 1995;119:173-8.
69. Russell Jones R, Orchard G, Zeiger B, Wilson Jones E. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol 1995;48:1011-6.
70. Mooy C, Vissers K, Luyten G, Mulder A, Stijnen T, Dejong P, Bosnian F. DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation. Br J Ophthalmol 1995;79:174-7.
71. Huntington A, Haugan P, Gamel J, McLean I. A simple cytologic method for predicting the malignant potential of intraocular melanoma. Pathol Res Pract 1989;185:631-4.
72. Pe'er J, Rummelt V, Mawn L, Hwang T, Woolson RF, Folberg R. Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas. Ophthalmology 1994;101:1227-35.
73. Coleman K, Baak JPA, van Diest PJ, Mullaney J. Prognostic value of morphometric features and the Callender classification in uveal melanomas. Ophthalmology 1996;103:1634-41.
74. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R. Expression of type VI collagen in uveal melanoma: role in pattern formation and tumor progression. Lab Invest 1996;75:55-66.
75. McDevitt CA, Marcelino J, Tucker L. Interactions of intact type VI collagen with hyaluronan. FEBS Lett 1991;294:167-70.
76. Kielty CM, Whittaker SP, Grant ME, Shuttleworth CA. Type VI collagen forms a structural association with hyaluronan in vivo. Biochem Soc Trans 1991;19:384S.
77. Sage EH, Vernon RB. Regulation of angiogenesis by extracellular matrix: the growth and the glue. J Hypertens 1994;12:S145-52.
78. Zhang LQ, Laato M, Muona P, Kalimo H, Peltonen J. Normal and hypertrophic scars: quantification and localization of messenger RNAs for type I, III and VI collagens. Br J Dermatol 1994;130:453-9.
79. Denis C, Baruch D, Kielty CM, Ajzenberg N, Christophe E, Meyer D. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. Arterioscler Thromb 1993;13:398-406.
80. Rand JH, Wu XX, Potter BJ, Uson RR, Gordon RE. Co-localization of von Willebrand factor and type VI collagen in human subendothelium. Am J Pathol 1993;142:843-50.
81. Hitraya EG, Tan EML, Rudnicka L, Jimenez SA. Expression of extracellular matrix genes in adult human dermal microvascular endothelial cells and their regulation by heparin and endothelial cell mitogens. Lab Invest 1995;73:393-402.
82. Marshall GE, Konstas AGP, Reid GG, Edwards JG, Lee WR. Collagens in the aged human macula. Graefes Arch Clin Exp Ophthalmol 1994;232:133-40.
83. Montesano R. Regulation of angiogenesis in vitro. Eur J Clin Invest 1992;22:504-15.
84. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983;101:1894-9.
85. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology 1995;102:844-51.
86. Speicher MR, Prescher G, du Manoir S, Jauch A, Horsthemke B, Bornfeld N, et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 1994;54: 3817-23.
87. Prescher G, Bornfeld N, Horsthemke B, Becher R. Chromosomal aberrations defining uveal melanoma of poor prognosis. Lancet 1992;339:691-2.
88. Augsburger JJ, Shields JA, Folberg R, Lang WR, O'Hara BJ, Claricci JD. Fine needle aspiration biopsy in the diagnosis of intraocular cancer cytologic-histologic correlations. Ophthalmology 1985;92:39-49.
89. Folberg R, Augsburger JJ, Gamel JW, Shields JA, Lang WR. Fine-needle aspirates of uveal melanomas and prognosis. Am J Ophthalmol 1985;100:654-7.
90. Char DH, Kroll SM, Stoloff A, Kaleta-Michaels S, Crawford JB, Miller TR et al. Cytomorphometry of uveal melanoma: comparison of fine needle aspiration biopsy samples with histologic sections. Anal Quant Cytol Histol 1991;13:293-9.
91. Bartsch D, Weinreb RN, Zinser G. Freeman WR. Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol 1995;120:642-51.
92. Coleman DJ, Lizzi FL, Silverman RH, Rondeau MJ, Smith MD, Torpey JH. Acoustic biopsy as a means for characterization of intraocular tumors. In: Henkind P, editor. Acta XXIV International Congress of Ophthalmology. Philadelphia: JB Lippincott. 1982: 115-8.
93. Schneider U, Gelisken F, Inhoffen W, Kreissig I. Indocyanine-green videoangiography of malignant melanomas of the choroid using the scanning laser ophthalmoscope. Ger J Ophthalmol 1996;5:6-11.
94. Coleman DJ, Silverman RH, Rondeau MJ, Lizzi FL, McLean IW, Jakobiec FA. Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death. Am J Ophthalmol 1990;110:380-8.
95. Coleman DJ, Silverman RH, Rondeau MJ, Coleman JA, Rosberger D, Ellsworth RM, Lizzi FL. Ultrasonic tissue characterization of uveal melanoma and prediction of patient survival after enucleation and brachytherapy. Am J Ophthalmol 1991;112:682-8.
96. Feleppa EJ, Lizzi FL, Coleman DJ, Yaremko MM. Diagnostic spectrum analysis in ophthalmology: a physical perspective. Ultrasound Med Biol 1986;12:623-31.
97. Coleman DJ, Rondeau MJ, Silverman RH, Folberg R, Rummelt V, Woods SM, Lizzi FL. Correlation of microcirculation architecture with ultrasound parameters of uveal melanoma. Eur J Ophthalmol 1995;5:96-106.
98. MacNeil S, Wagner M, Kirkham PR, Blankson EA, Lennard MS, Goodall T, Rennie IG. Inhibition of melanoma cell matrix interaction by tamoxifen. Melanoma Res 1993;3:67-74.
99. MacNeil S, Wagner M, Rennie IG. Tamoxifen inhibition of ocular melanoma cell attachments to matrix proteins. Pigment Cell Res 1994;7:222-6.
100. MacNeil S, Wagner M, Rennie IG. Investigation of the role of signal transduction in attachment of ocular melanoma cells to matrix proteins: inhibition of attachment by calmodulin antagonists including tamoxifen. Clin Exp Med 1994;12:375-84.
101. Hilmas DE, Gillette EL. Morphometric analyses of the microvasculature of tumors during growth and after x-irradiation. Cancer 1974;33:103-10.
102. Falk P. Differences in vascular pattern between the spontaneous and the transplanted C3H mouse mammary carcinoma. Eur J Cancer Clin Oncol 1982; 18:155-65.
103. 106Rh ophthalmic applicators. Graefes Arch Clin Exp Ophthalmol 1991;229:480-6.
104. Finger PT. Microwave plaque thermodiotherapy for choroidal melanoma. Br J Ophthalmol 1992;76: 358-64.
105. Storm FK, Harrison WH, Eliott RS, Hatzitheofilou C, Morton DL. Human hyperthermic therapy: relation between tumor type and capacity to induce hyperthermia by radiofrequency. Am J Surg 1979;138:170-4.
106. Coleman DJ, Silverman RH, Iwamoto T, Lizzi FL, Rondeau MJ, Driller J, et al. Histopathologic effects of ultrasonically induced hyperthermia in intraocular malignant melanoma. Ophthalmology 1988;95:970-81.
107. Endrich B, Hammersen F, Messmer K. Hyperthermia-induced changes in tumor microcirculation. Recent Results Cancer Res 1988;107:44-59.
108. Munzenrider JE, Gragoudas ES, Seddon JM, Sisterson J, McNulty P, Birnbaum S, et al. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J. Radiat Oncol Phys 1988;15:553-8.
109. Oosterhuis JA, Journeedekorver HG, Kakebeekekemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melamomas. Arch Ophthalmol 1995;113:315-21.
110. Steeves RA, Tompkins DT, Nash RN, Blair JR, Gentry LL, Paliwal BR, et al. Thermoradiotherapy of intraocular tumors in an animal model: concurrent vs sequential brachytherapy and ferromagnetic hyperthermia. Int J Radiat Oncol Biol Phys 1995; 33:659-62.
111. Zolzer F, Streffer C. Cell cycle-dependent expression of Ki-67 antigen in human melanoma cells subjected to irradiation and/or hyperthermia. Radiat Res 1995; 143:98-101.
112. Harris AL, Zhang HT, Moghaddam A, Fox S, Scott P, Pattison A, et al. Breast cancer angiogenesis: new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat 1996;38:97-108.